Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for back pain after surgery: injections and needling put to the test

NCT ID NCT07555496

First seen Apr 30, 2026 · Last updated Jun 21, 2026 · Updated 8 times

Summary

This study will test two treatments for people with chronic low back pain who have already had spinal surgery. One treatment is an injection of a steroid and numbing medicine into the back muscles, and the other is dry needling (inserting thin needles into the same muscles). Both are done with ultrasound guidance. The goal is to see if these treatments can reduce pain and improve function, helping patients get more out of physical therapy. The study plans to enroll 120 participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACK PAIN LOWER BACK CHRONIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emerald Coast Clinic

    St-Malo, 35400, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

corticosteroid injection (Diprostene) and lidocaine

What this could lead to

If successful, this could provide a new, minimally invasive option to ease chronic back pain after spinal surgery and help patients better engage in rehabilitation.

What could go wrong

This is a small, early-stage study that has not yet started recruiting. The treatment involves steroids, which carry risks like infection or tissue damage, and the results may not apply to all back pain patients.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.